| |
|
|
|
Intec Pharma Ltd  
|
|
9.63 -1.37 (-0.12%) |
08-03 16:00 |
|
Open: |
11 |
Pre close: |
11 |
Target:
|
16.80
|
|
High: |
11.0973 |
Low: |
9.59 |
Resistance:
|
14.38
17.80
|
|
Volume: |
988,303 |
Market Cap: |
46M |
Support:
|
8.86
7.37
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.92
 |
MACD |
MACD(12,26):
|
-1.01  |
|
MA(20): |
12.37 |
Signal(12,26,9): |
-0.81 |
|
MA(100): |
15.33 |
Stochastic Oscillator |
%K(14,3):
|
19.92 |
|
MA(250): |
17.42 |
%D(3): |
27.39 |
|
Average Volume(K) |
3-Month: |
109909
|
52-Week |
High:
|
36.80 |
|
10-Days: |
448457 |
Low: |
8.80 |
|
RSI |
RSI(14):
|
39.14 |
Change(%): |
-70.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.640 |
Return on Equity (ttm) |
-113.3 |
Shares Out. (M) |
4.82 |
|
EPS Est. Current Year |
-1.670 |
Return on Assets (ttm) |
-45.7 |
Shares Float (M) |
4.69 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.72 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.40 |
|
Forward EPS |
-1.410 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
456 |
|
Book Value (p.s.) |
2.520 |
EBITDA (p.s.) |
-2.591 |
P/E |
-2.65 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.82 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.68 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.86 |
P/CF |
-4.35 |
|
|
|
|
|
|
